Revenue

Private equity giants Kelso & ARA back Beacon Communications, signaling a major expansion for the vital security and communication technology provider.

As the NCAA tournament ended, GEICO’s real victory was off the court, using its sponsorship to invest in youth sports and redefine corporate impact.

With new capital and two industry heavyweights on its board, Armada Analytics signals a bold strategy to expand its market leadership in real estate services.

The iconic sauce brand blends 400 years of tradition with anime and bold new flavors in a major push to capture the adventurous palates of Gen Z.

A new report reveals massive consolidation in U.S. payments, with giants processing trillions and innovators like Stripe rapidly climbing the ranks.

With a new marketing chief known for explosive growth, the world's largest kids coding franchise aims to build a predictable success engine for its 350+ centers.

Amid claims of undervaluation and AI-driven momentum, the cybersecurity giant escalates its share repurchase plan, signaling deep confidence in its future.

dōTERRA's foundation is aiding Hawaiʻi flood victims with emergency kits, hygiene products, and a $25,000 donation match in partnership with Lāhui Foundation.

GA Group's strategic acquisition of G2 Capital Advisors creates a full-lifecycle advisory and investment banking platform for the middle market.

As businesses move AI from pilot to production, Teradata's CRN AI 100 award highlights its focus on governance, scale, and a powerful partner ecosystem.

The fast-casual chain's recent industry awards reveal a sophisticated strategy combining tech, training, and a unique franchisee partnership model.

Following a string of 14 acquisitions, IMS Legal Strategies is sold. The deal highlights major trends in private equity and the future of legal services.

New York Medicaid now funds a vital therapy to prevent chemo-induced hair loss, breaking down financial barriers for low-income cancer patients.

Decoy Therapeutics touts a revolutionary AI platform for multi-virus drugs, but faces financial hurdles. An upcoming investor event could define its future.

A Charlotte dentist’s late-night parenting struggle sparks a patented invention, disrupting a beloved childhood tradition and making her a national innovator.

Enlyte's acquisition of PartsTrader signals a major shift in the auto claims industry, promising more efficiency but raising questions about competition.

The indoor air quality giant launches its roadshow, seeking to pay down debt and capitalize on soaring demand for healthier buildings and AI infrastructure.

Vyome is set to present promising Phase 2 data for VT-1953, a first-in-class treatment for a debilitating cancer complication with no approved drugs.

In a pivotal move from R&D to commercial scale, Zivo Bioscience partners with industry leader Cyanotech to meet global demand for its unique algal biomass.

New data shows companies working with CEO Coaching International are seeing revenue and profit growth that nearly doubles and triples U.S. market averages.